print this page | email this page
Video Spotlight
Meet the researchers funded by the Glaucoma Research Foundation and learn about the innovative methods they are using to speed the cure for glaucoma.
Catalyst For a Cure: David Calkins, PhD (Video)
David J. Calkins, PhD, Associate Professor of Ophthalmology at the Vanderbilt Eye Institute speaks on:
- Catalyst For a Cure (CFC): A New Model for Scientific Research
- Benefits of Collaborative Research
- The Focus of CFC Research
- A Neurobiological Approach to Glaucoma Research
“The Catalyst For a Cure is unique in that it represents a new model for doing biomedical research.”
Catalyst For a Cure: Nicholas Marsh-Armstrong, PhD (Video)
Nicholas Marsh-Armstrong, PhD, Assistant Professor at the Kennedy Krieger Institute, Johns Hopkins University discusses:
- Catalyst For a Cure: A Fresh Perspective to Glaucoma Research
- Collaborative Research
- Recent Major Findings
- Advancing the Field of Glaucoma Research
“If the whole scientific environment was structured in this way, the speed of curing glaucoma and other diseases would be accelerated tremendously.”
Catalyst For a Cure: Monica Vetter, PhD
Monica Vetter, PhD, Professor, Department of Neurobiology & Anatomy
at the University of Utah School of Medicine discusses:
- Early Genetic Changes in Glaucoma
- Goal: Preserving Vision
- Promise for Therapeutic Interventions
- Translational Research
- Research Focused on a Cure for Glaucoma
Dr. Vetter is one of four principal investigators in the Catalyst For a Cure research consortium, funded by the Glaucoma Research Foundation.